With over 17 years of expertise dedicated to improving data quality, we provide specialized clinical service solutions that seamlessly combine science, technology, and innovation to drive successful outcomes. By collaborating directly with sponsors, either as part of a full contract with IQVIA clinical research teams or through a third-party CRO, we deliver tailored solutions specifically designed for CNS indications.
These Rater Services ensure that neurological and psychiatric clinical trials overcome unique challenges – including bias, variability, and human error – resulting in accurate, reliable data that supports confident decision-making and accelerates your study’s success.
Our Rater Services are designed to address common sources of variability and risk throughout the study lifecycle, including:
IQVIA Rater Services are designed to support high quality, defensible COA data and align with evolving regulatory expectations across global clinical trials.
Our Rater Services are backed by deep scientific and operational expertise across psychiatric and neurological indications, including:
Customers benefit from our extensive team of subject matter experts and key global clinical specialists by receiving highly knowledgeable and culturally competent support across a wide range of therapeutic areas and languages, ensuring accurate, tailored, and effective solutions.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
Capture the patient experience across the full trial process, from strategy to dissemination of results.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
.svg){kind=icon}
